• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Woodford Patient Capital Trust Plc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Woodford Investment Management Ltd
Fund Summary The Company's investment objective is to achieve long-term capital growth through investing in a portfolio consisting predominantly of UK Companies, both quoted and unquoted. The Company will aim to deliver a return in excess of 10 per cent. per annum over the longer term. This is a target only and not a profit forecast and there can be no assurance that it will be met.
Fund code WPCT
Managers Neil Woodford
Manager Tenure 4 years
Morningstar Category Currently unavailable
Fund Size Currently unavailable
Fund Type ETF / IT
Management Style Active
Total Expense Ratio (TER) 0.2%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £0.431
Buy Price £0.438
Price Change +0.1161%
Price Date 19th August 2019
Yield Currently unavailable
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 21st April 2015
Fund Status OPEN
Neil Woodford began his career at Dominion Insurance in 1981 and then worked in the corporate finance departments of Reed International and TSB before focusing on fund management at Eagle Star in 1987. Following a brief stint there, Woodford joined Perpetual in 1988 and rose to head of investment at the firm. He ran the IP Income fund from 1990 and also took charge of the IP High Income at launch in 1988. He was appointed a Commander of the Order of the British Empire (CBE) in 2013 for services to the economy. Woodford announced he was leaving Invesco Perpetual in October 2013 to set up his own fund management business. He joined Woodford Investment Management on 1 May 2014.

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017 2016 2015
Fund Performance -10.20% -8.32% +15.85% -14.59%
Benchmark Performance
-14.05% +5.63% +47.38%
Time Period Cumulative Benchmark Performance
Fund Compared to Benchmark
1 day -0.68% -0.09% -0.59%
1 week -2.56% +1.74% -4.29%
1 month -18.80% +3.47% -22.27%
3 months -47.17% +8.87% -56.03%
6 months -49.01% +13.34% -62.35%
1 year -44.77% +7.99% -52.76%
3 years -53.05% +60.82% -113.87%
5 years Currently unavailable +71.67% Currently unavailable
10 years Currently unavailable +272.15% Currently unavailable
YTD -46.59% +19.58% -66.17%
Since inception -56.94% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Benevolentai 9.81%
Oxford Nanopore Tech Ord 8.32%
Autolus Therapeutics PLC ADR GBR 8.26%
Crossco (1337) Plc 8.07%
Proton Partners International Ltd GBR 7.34%
Immunocore Ltd Series 5.64%
Oxford Sciences Plc 4.62%
Mission Therapeutics 'c' 2.15%

Currently unavailable